Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Study on Locally Advanced Non Small Cell Lung Cancer Escalated Dose on Individual Basis Treatment With Radiochemotherapy

NCT01664663 is registered in ClinicalTrials.gov with Ass. Prof. Jan Nyman as lead sponsor.

NCT NCT01664663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01664663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Study on Locally Advanced Non Small Cell Lung Cancer Escalated Dose on Individual Basis Treatment With Radiochemotherapy
Lead sponsor
Ass. Prof. Jan Nyman
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2011
Completion date
October 31, 2015
Enrollment
37 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced disease, non small cell lung cancer